# INNOCAN PHARMA Corp — Form D

INNOCAN PHARMA Corp of CALGARY, A0, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-26. The offering totals $6.6M, of which $6.6M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-10-26
- Form: D
- Accession: 0001213900-21-054585
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.6M
- Amount sold: $6.6M
- Investors: 8
- Date of first sale: 2021-10-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-418536

## Issuer

- Name: INNOCAN PHARMA Corp
- CIK: 0001889791
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Incorporated: 2018
- Address: 1015, 926 - 5 AVENUE SW, CALGARY, A0, T2P 0N7
- Phone: 403-777-1519

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| Iris Bincovich | Director | Calgary, A0 |
| Peter A Bloch | Director | Calgary, A0 |
| Ralph Bossino | Director | Calgary, A0 |
| Yoram Drucker | Director | Technion City, Haifa, L3 |
| Eyal Flom | Director | Calgary, A0 |
| Joshua A Lintern | Director | Calgary, A0 |
| Ron Mayron | Director | CAESAREA, L3 |
| Iris Bincovich | Executive Officer | Calgary, A0 |
| Yoram Drucker | Executive Officer | Technion City, Haifa, L3 |
| Nelson A Halpen | Executive Officer | Calgary, A0 |
| Ron Mayron | Executive Officer | CAESAREA, L3 |

## More

- [CIK 1889791 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1889791&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001213900-21-054585.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.